back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-05 15:53 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-87,803 vol |
378,181 | |
| Filed 2024-03-05 15:52 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+174,385 vol |
465,984 | |
| Filed 2024-03-05 15:51 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-174,385 vol |
923,642 | |
| Filed 2024-03-05 15:50 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-23,871 vol |
291,599 | |
| Filed 2024-03-05 15:49 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,897 vol |
315,470 | |
| Filed 2024-03-05 15:48 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,897 vol |
1,098,027 | |
| Filed 2024-03-05 15:47 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-2,413 vol |
264,573 | |
| Filed 2024-03-05 15:46 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,944 vol |
266,986 | |
| Filed 2024-03-05 15:45 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,944 vol |
1,148,924 | |
| Filed 2024-03-05 15:44 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-2,895 vol |
262,042 | |
| Filed 2024-03-05 15:44 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,932 vol |
264,937 | |
| Filed 2024-03-05 15:42 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,932 vol |
1,153,868 | |
| Filed 2024-03-04 18:18 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+519,328 vol |
1,159,800 | |
| Filed 2023-09-05 18:21 Tx date 2023-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-119,379.06
-14,111 vol $8.46 each |
259,005 | |
| Filed 2023-09-05 18:20 Tx date 2023-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$254,536
+30,087 vol $8.46 each |
273,116 | |
| Filed 2023-09-05 18:20 Tx date 2023-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-30,087 vol |
640,472 | |
| Filed 2023-03-06 18:34 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,445.32
-1,577 vol $9.16 each |
243,029 | |
| Filed 2023-03-06 18:33 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-17,339.88
-1,893 vol $9.16 each |
244,606 | |
| Filed 2023-03-06 18:32 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-21,590.12
-2,357 vol $9.16 each |
246,499 | |
| Filed 2023-03-06 18:31 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-39,827.68
-4,348 vol $9.16 each |
248,856 | |
| Filed 2023-03-06 18:30 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$117,419
+12,694 vol $9.25 each |
253,204 | |
| Filed 2023-03-06 18:29 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,943 vol |
670,559 | |
| Filed 2023-03-06 18:29 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,932 vol |
675,502 | |
| Filed 2023-03-06 18:28 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-6,881 vol |
121,770 | |
| Filed 2023-03-06 18:27 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-12,694 vol |
128,651 | |
| Filed 2023-03-06 18:25 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-161,246
-17,432 vol $9.25 each |
240,510 | |
| Filed 2023-03-06 18:23 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$470,788
+50,896 vol $9.25 each |
257,942 | |
| Filed 2023-03-06 18:23 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,896 vol |
681,434 | |
| Filed 2023-03-06 18:21 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$4,839,183
+523,155 vol $9.25 each |
732,330 | |
| Filed 2023-03-01 18:24 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-40,749.06
-4,258 vol $9.57 each |
207,046 | |
| Filed 2023-03-01 18:23 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$119,117
+12,447 vol $9.57 each |
211,304 | |
| Filed 2023-03-01 18:22 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-12,447 vol |
141,345 | |
| Filed 2023-03-01 18:21 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-19,800.33
-2,069 vol $9.57 each |
198,857 | |
| Filed 2023-03-01 18:21 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$62,042
+6,483 vol $9.57 each |
200,926 | |
| Filed 2023-03-01 18:20 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,483 vol |
209,175 | |
| Filed 2022-10-07 16:36 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Appio, Thomas
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+55,555 vol |
55,555 | |
| Filed 2022-10-07 16:36 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Appio, Thomas
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-06 10:22 Tx date 2022-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-101,413.51
-15,389 vol $6.59 each |
194,443 | |
| Filed 2022-09-06 10:21 Tx date 2022-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$198,266
+30,086 vol $6.59 each |
209,832 | |
| Filed 2022-09-06 10:21 Tx date 2022-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-30,086 vol |
215,658 | |
| Filed 2022-05-16 16:46 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$117,001
+12,447 vol $9.40 each |
134,217 | |
| Filed 2022-05-16 16:45 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$184,005
+19,575 vol $9.40 each |
153,792 | |
| Filed 2022-05-16 16:43 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$-117,001.80
-12,447 vol $9.40 each |
||
| Filed 2022-03-08 10:35 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-131,366.04
-5,564 vol $23.61 each |
179,746 | |
| Filed 2022-03-08 10:33 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$256,758
+10,875 vol $23.61 each |
185,310 | |
| Filed 2022-03-08 10:31 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,875 vol |
245,744 | |
| Filed 2022-03-04 17:12 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+565,330 vol |
852,455 | |
| Filed 2022-03-04 17:11 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$3,690,517
+152,690 vol $24.17 each |
256,619 | |
| Filed 2022-03-03 17:35 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-58,488.70
-2,402 vol $24.35 each |
174,435 | |
| Filed 2022-03-03 17:34 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-53,375.20
-2,192 vol $24.35 each |
154,223 | |
| Filed 2022-03-03 17:33 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$172,982
+7,104 vol $24.35 each |
176,837 | |
| Filed 2022-03-03 17:32 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$157,861
+6,483 vol $24.35 each |
156,415 | |
| Filed 2022-03-03 17:30 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,104 vol |
103,929 | |
| Filed 2022-03-03 17:29 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,483 vol |
111,033 | |
| Filed 2022-03-03 17:26 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-213,841.70
-8,782 vol $24.35 each |
169,733 | |
| Filed 2022-03-03 17:25 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$591,510
+24,292 vol $24.35 each |
178,515 | |
| Filed 2022-03-03 17:24 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-24,292 vol |
121,770 | |
| Filed 2022-03-03 17:23 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,292 vol |
146,062 | |
| Filed 2021-12-16 18:19 Tx date 2021-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-84,759.89
-3,461 vol $24.49 each |
149,932 | |
| Filed 2021-12-16 18:17 Tx date 2021-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$207,675
+8,480 vol $24.49 each |
153,393 | |
| Filed 2021-12-16 18:16 Tx date 2021-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,480 vol |
117,516 | |
| Filed 2021-09-07 12:49 Tx date 2021-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+90,260 vol |
121,770 | |
| Filed 2021-09-07 12:48 Tx date 2021-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+90,260 vol |
125,996 | |
| Filed 2021-03-11 18:19 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-576,315.60
-17,480 vol $32.97 each |
144,913 | |
| Filed 2021-03-11 18:18 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,388 vol |
162,393 | |
| Filed 2021-03-11 18:18 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,305 vol |
155,005 | |
| Filed 2021-03-11 18:16 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,388 vol |
35,736 | |
| Filed 2021-03-11 18:15 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-37,305 vol |
31,510 | |
| Filed 2021-03-05 18:43 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+23,728 vol |
68,815 | |
| Filed 2021-03-05 18:39 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+47,151 vol |
287,125 | |
| Filed 2021-03-05 18:35 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+32,626 vol |
43,124 | |
| Filed 2021-03-03 20:18 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-170,799.12
-5,436 vol $31.42 each |
117,700 | |
| Filed 2021-03-03 20:17 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$426,872
+13,586 vol $31.42 each |
123,136 | |
| Filed 2021-03-03 20:17 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,586 vol |
10,498 | |
| Filed 2020-12-21 11:41 Tx date 2020-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-66,446.64
-3,224 vol $20.61 each |
109,550 | |
| Filed 2020-12-21 11:40 Tx date 2020-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$174,772
+8,480 vol $20.61 each |
112,774 | |
| Filed 2020-12-21 11:39 Tx date 2020-12-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-174,772.80
-8,480 vol $20.61 each |
24,084 | |
| Filed 2020-03-12 10:19 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-57,304.64
-2,734 vol $20.96 each |
104,294 | |
| Filed 2020-03-12 10:18 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$154,831
+7,387 vol $20.96 each |
107,028 | |
| Filed 2020-03-12 10:17 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-154,831.52
-7,387 vol $20.96 each |
32,564 | |
| Filed 2020-03-11 17:06 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-68,334.24
-2,796 vol $24.44 each |
99,641 | |
| Filed 2020-03-11 17:05 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$173,597
+7,103 vol $24.44 each |
102,437 | |
| Filed 2020-03-11 17:04 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-173,597.32
-7,103 vol $24.44 each |
39,951 | |
| Filed 2020-03-11 16:23 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+12,966 vol |
45,087 | |
| Filed 2020-03-11 16:22 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+12,966 vol |
32,121 | |
| Filed 2020-03-11 16:21 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+81,873 vol |
239,974 | |
| Filed 2020-03-11 16:20 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+19,449 vol |
47,054 | |
| Filed 2020-02-28 17:27 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-261,054.36
-9,866 vol $26.46 each |
95,334 | |
| Filed 2020-02-28 17:26 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$559,179
+21,133 vol $26.46 each |
105,200 | |
| Filed 2020-02-28 17:26 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$103,883
+3,932 vol $26.42 each |
84,067 | |
| Filed 2020-02-28 17:25 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-8,192 vol |
19,155 | |
| Filed 2020-01-10 12:20 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-53,750.34
-1,827 vol $29.42 each |
80,135 | |
| Filed 2020-01-10 12:19 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$120,504
+4,096 vol $29.42 each |
81,962 | |
| Filed 2020-01-10 12:18 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-120,504.32
-4,096 vol $29.42 each |
27,605 | |
| Filed 2019-12-18 12:16 Tx date 2019-12-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-103,447
-3,337 vol $31.00 each |
77,866 | |
| Filed 2019-12-18 12:15 Tx date 2019-12-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$262,880
+8,480 vol $31.00 each |
81,203 | |
| Filed 2019-12-18 12:14 Tx date 2019-12-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,480 vol |
31,701 | |
| Filed 2019-08-26 18:34 Tx date 2019-08-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-178,110.60
-8,362 vol $21.30 each |
72,723 | |
| Filed 2019-08-26 18:34 Tx date 2019-08-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$452,582
+21,248 vol $21.30 each |
81,085 | |
| Filed 2019-08-26 18:33 Tx date 2019-08-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-21,248 vol |
40,181 | |
| Filed 2019-07-23 19:43 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,592.50
-1,722 vol $21.25 each |
55,357 | |
| Filed 2019-07-23 19:42 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$87,040
+4,096 vol $21.25 each |
57,079 | |
| Filed 2019-07-23 19:41 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,096 vol |
47,506 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-68,488.92
-2,907 vol $23.56 each |
57,463 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$174,037
+7,387 vol $23.56 each |
60,370 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-174,037.72
-7,387 vol $23.56 each |
65,525 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+62,004 vol |
158,101 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+21,310 vol |
72,912 | |
| Filed 2018-08-26 Tx date 2018-08-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$460,847
+21,247 vol $21.69 each |
58,484 | |
| Filed 2018-08-26 Tx date 2018-08-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-21,247 vol |
51,602 | |
| Filed 2018-08-26 Tx date 2018-08-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-119,316.69
-5,501 vol $21.69 each |
52,983 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+22,162 vol |
72,849 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+14,776 vol |
27,347 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,009,940
+65,923 vol $15.32 each |
96,097 | |
| Filed 2018-01-30 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-37,134.45
-1,557 vol $23.85 each |
||
| Filed 2018-01-30 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-30,146.40
-1,264 vol $23.85 each |
37,237 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-37,134.45
-1,557 vol $23.85 each |
36,944 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,095 vol |
50,687 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$97,665
+4,095 vol $23.85 each |
38,501 | |
| Filed 2017-08-24 Tx date 2017-08-18 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-300,645.05
-21,247 vol $14.15 each |
54,782 | |
| Filed 2017-08-24 Tx date 2017-08-18 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$300,645
+21,247 vol $14.15 each |
40,093 | |
| Filed 2017-08-24 Tx date 2017-08-18 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-80,471.05
-5,687 vol $14.15 each |
34,406 | |
| Filed 2017-05-15 Tx date 2017-05-10 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-12,230 vol |
76,029 | |
| Filed 2017-05-15 Tx date 2017-05-10 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-31,790.54
-3,274 vol $9.71 each |
18,846 | |
| Filed 2017-05-15 Tx date 2017-05-10 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$118,753
+12,230 vol $9.71 each |
22,120 | |
| Filed 2017-03-30 Tx date 2017-03-28 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+63,742 vol |
88,259 | |
| Filed 2017-03-06 Tx date 2016-08-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-06 Tx date 2017-03-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$433,902
+30,174 vol $14.38 each |
30,174 | |
| Filed 2017-01-11 Tx date 2017-01-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+12,287 vol |
24,517 | |
| Filed 2017-01-11 Tx date 2017-01-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+4,096 vol |
12,571 | |
| Filed 2016-09-06 Tx date 2016-08-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
8,475 | ||
| Filed 2016-09-06 Tx date 2016-08-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
12,230 | ||
| Filed 2016-09-06 Tx date 2016-08-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,890 |